Anzeige
Mehr »
Login
Samstag, 19.04.2025 Börsentäglich über 12.000 News von 690 internationalen Medien
Trumps Dekret beschleunigt Antimon-Boom - Wird Global Tactical der nächste Highflyer für kritische Mineralien?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A11664 | ISIN: US03209R1032 | Ticker-Symbol: 29A
München
17.04.25
08:00 Uhr
20,490 Euro
-0,390
-1,87 %
1-Jahres-Chart
AMPHASTAR PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
AMPHASTAR PHARMACEUTICALS INC 5-Tage-Chart
RealtimeGeldBriefZeit
20,30020,80017.04.
20,32020,73017.04.

Aktuelle News zur AMPHASTAR Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
03.04.Amphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference197RANCHO CUCAMONGA, CA / ACCESS Newswire / April 3, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Dan Dischner, SVP of Corp. Communication, will be participating...
► Artikel lesen
28.03.Amphastar Pharmaceuticals, Inc.: International Medication Systems, Ltd. Receives FDA's Drug Shortage Assistance Award1.498Recognized for contributions to address shortage of epinephrine injection, 0.1 mg/mL syringes RANCHO CUCAMONGA, CA / ACCESS Newswire / March 28, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)...
► Artikel lesen
21.03.Amphastar stock target cut to $32 by Piper Sandler, maintains neutral2
05.03.Amphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals to Present at the Barclays 27th Annual Global Healthcare Conference414RANCHO CUCAMONGA, CA / ACCESS Newswire / March 5, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Tony Marrs, EVP of Regulatory Affairs and Clinical Operations...
► Artikel lesen
03.03.Amphastar Pharmaceuticals, Inc. - 10-K, Annual Report4
28.02.Specialty Pharma Amphastar Stock Falls On Lower Than Expected Q4 Earnings, Analyst Sees Competitive Headwinds9
27.02.Amphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2024287Reports Net Revenues of $186.5 Million for the Three Months Ended December 31, 2024 RANCHO CUCAMONGA, CA / ACCESS Newswire / February 27, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar"...
► Artikel lesen
27.02.Amphastar Pharmaceuticals, Inc. - 8-K, Current Report4
AMPHASTAR Aktie jetzt für 0€ handeln
20.02.Amphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 27, 2025290RANCHO CUCAMONGA, CA / ACCESS Newswire / February 20, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its Fourth quarter of 2024 ended December...
► Artikel lesen
04.02.Piper Sandler cuts Amphastar stock rating, slashes price target14
08.01.Amphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference341RANCHO CUCAMONGA, CA / ACCESSWIRE / January 8, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jack Zhang, CEO and President, and Bill Peters, CFO will be presenting at the...
► Artikel lesen
30.11.24Why Amphastar Pharmaceuticals (AMPH) Is One of the Most Profitable Pharmaceutical Stocks Right Now?7
26.11.24Amphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals to Present at the 36th Annual Piper Sandler Healthcare Conference703RANCHO CUCAMONGA, CA / ACCESSWIRE / November 26, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Dan Dischner SVP of Corp. Communication, will participate...
► Artikel lesen
13.11.24Amphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference417RANCHO CUCAMONGA, CA / ACCESSWIRE / November 13, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Jacob Liawatidewi, EVP of Corporate Administration, will...
► Artikel lesen
07.11.24Amphastar Pharmaceuticals, Inc. - 10-Q, Quarterly Report7
06.11.24Amphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2024373Reports Net Revenues of $191.2 Million for the Three Months Ended September 30, 2024RANCHO CUCAMONGA, CA / ACCESSWIRE / November 6, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar"...
► Artikel lesen
06.11.24Amphastar Pharmaceuticals, Inc. - 8-K, Current Report1
29.10.24Amphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6, 2024217RANCHO CUCAMONGA, CA / ACCESSWIRE / October 29, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its third quarter of 2024 ended September 30...
► Artikel lesen
28.08.24Amphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference337RANCHO CUCAMONGA, CA / ACCESSWIRE / August 28, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Tony Marrs, EVP of Regulatory Affairs and Clinical Operations...
► Artikel lesen
07.08.24Amphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2024233Reports Net Revenues of $182.4 Million for the Three Months Ended June 30, 2024RANCHO CUCAMONGA, CA / ACCESSWIRE / August 7, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the...
► Artikel lesen
Seite:  Weiter >>
27 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1